EPISODE · May 28, 2015 · 58 MIN
First Rounder: Colin Goddard
from First Rounders
Colin Goddard is former CEO of OSI Pharmaceuticals, and current chairman and CEO of Coferon. His conversation with Nature Biotechnology details the history behind OSI's blockbuster drug Tarceva (erlotinib), the benefits of having a British accent in the United States and how to survive a hostile takeover. Hosted on Acast. See acast.com/privacy for more information.
Embed this episode
NOW PLAYING
First Rounder: Colin Goddard
0:00
58:09
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of First Rounders?
This episode is 58 minutes long.
When was this First Rounders episode published?
This episode was published on May 28, 2015.
Can I download this First Rounders episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!